ImmuCell Corp
NASDAQ:ICCC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
ImmuCell Corp
NASDAQ:ICCC
|
US |
|
Dongguan Yiheda Automation Co Ltd
SZSE:301029
|
CN |
|
K
|
Kerry Express (Thailand) PCL
SET:KEX
|
TH |
|
Laramide Resources Ltd
TSX:LAM
|
CA |
|
Cahayasakti Investindo Sukses Tbk PT
IDX:CSIS
|
ID |
|
Kunlun Energy Company Ltd
HKEX:135
|
HK |
|
S
|
Spiritus Mundi PLC
LSE:SPMU
|
UK |
|
NZME Ltd
NZX:NZM
|
NZ |
|
Z
|
Zhejiang Zoenn Design Co Ltd
SZSE:300901
|
CN |
|
N
|
Niterra Co Ltd
XMUN:NGK
|
JP |
|
Resorttrust Inc
TSE:4681
|
JP |
|
N
|
Nanjing Medlander Medical Technology Co Ltd
SSE:688273
|
CN |
|
KraussMaffei Co Ltd
SSE:600579
|
CN |
|
C
|
Creativeforge Games SA
WSE:CFG
|
PL |
|
D
|
Danhua Chemical Technology Co Ltd
SSE:600844
|
CN |
|
Fanli Digital Technology Co Ltd
SSE:600228
|
CN |
|
Penguin International Ltd
SGX:BTM
|
SG |
ImmuCell Corp
ImmuCell Corp. engages in the development, acquisition, manufacture and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company is headquartered in Portland, Maine and currently employs 60 full-time employees. The firm is engaged in development, acquisition, manufacture and sale of products that improve the health and productivity of dairy and beef cattle. The company manufactures and markets the First Defense product line for the prevention of scours in newborn dairy and beef calves. The company expanded this line into five different products with formulations targeting E. coli and coronavirus pathogens, as well as E. coli, coronavirus and rotavirus pathogens. Its Tri-Shield First Defense product line extension is calf-level, passive antibody product providing immediate immunity against E. coli, coronavirus and rotavirus. These product line provides Immediate Immunity to newborn calves. The firm is engaged in development of Re-Tain, a Nisin treatment for subclinical mastitis in lactating dairy cows. Its products reduce the use of traditional antibiotics in food producing animals.
ImmuCell Corp. engages in the development, acquisition, manufacture and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company is headquartered in Portland, Maine and currently employs 60 full-time employees. The firm is engaged in development, acquisition, manufacture and sale of products that improve the health and productivity of dairy and beef cattle. The company manufactures and markets the First Defense product line for the prevention of scours in newborn dairy and beef calves. The company expanded this line into five different products with formulations targeting E. coli and coronavirus pathogens, as well as E. coli, coronavirus and rotavirus pathogens. Its Tri-Shield First Defense product line extension is calf-level, passive antibody product providing immediate immunity against E. coli, coronavirus and rotavirus. These product line provides Immediate Immunity to newborn calves. The firm is engaged in development of Re-Tain, a Nisin treatment for subclinical mastitis in lactating dairy cows. Its products reduce the use of traditional antibiotics in food producing animals.
This earnings call has not been analyzed yet.
If you’d like us to analyze this earnings call, click the "Request Earnings Call Analysis" button below.
